These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 9654209)

  • 1. Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator.
    Mekus F; Ballmann M; Bronsveld I; Dörk T; Bijman J; Tümmler B; Veeze HJ
    Hum Genet; 1998 May; 102(5):582-6. PubMed ID: 9654209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of cystic fibrosis.
    De Boeck K; Vermeulen F; Dupont L
    Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
    Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
    World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetics principles in cystic fibrosis. An example of genetic illness in pneumology].
    Tümmler B; Stuhrmann M
    Internist (Berl); 2003 Jun; 44 Suppl 1():S7-15. PubMed ID: 14567084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive
    Minso R; Schulz A; Dopfer C; Alfeis N; Barneveld AV; Makartian-Gyulumyan L; Hansen G; Junge S; Müller C; Ringshausen FCC; Sauer-Heilborn A; Stanke F; Stolpe C; Tamm S; Welte T; Dittrich AM; Tümmler B
    BMJ Open Respir Res; 2020 Oct; 7(1):. PubMed ID: 33020115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
    Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
    Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
    Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
    Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests for the diagnosis of cystic fibrosis.
    Wang L; Freedman SD
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S109-15. PubMed ID: 14569807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and genetic analysis of cystic fibrosis transmembrane conductance reseptor-related disease.
    Kilinc AA; Alishbayli G; Taner HE; Cokugras FC; Cokugras H
    Pediatr Int; 2020 May; 62(5):629-633. PubMed ID: 32003094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
    Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M
    Respiration; 2006; 73(5):698-704. PubMed ID: 16763370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of exclusive cystic fibrosis lung disease.
    Bronsveld I; Bijman J; Mekus F; Ballmann M; Veeze HJ; Tümmler B
    Thorax; 1999 Mar; 54(3):278-81. PubMed ID: 10325907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
    Pagin A; Sermet-Gaudelus I; Burgel PR
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
    Kerem E; Rave-Harel N; Augarten A; Madgar I; Nissim-Rafinia M; Yahav Y; Goshen R; Bentur L; Rivlin J; Aviram M; Genem A; Chiba-Falek O; Kraemer MR; Simon A; Branski D; Kerem B
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1914-20. PubMed ID: 9196095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.